Johnson Investment Counsel Inc. Buys 898 Shares of Intuitive Surgical, Inc. $ISRG

Johnson Investment Counsel Inc. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,042 shares of the medical equipment provider’s stock after purchasing an additional 898 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $15,782,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last quarter. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 3.2%

Shares of NASDAQ:ISRG opened at $429.59 on Friday. The company’s 50 day moving average price is $458.68 and its two-hundred day moving average price is $497.91. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market cap of $154.00 billion, a PE ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 EPS. The business’s revenue was up 21.4% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent research reports. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. Evercore ISI cut their price target on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday, October 7th. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday. Finally, UBS Group boosted their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.